Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector

All

NEJM opinion

Mar 2025

Keys to harnessing the value of digital biomarkers in clinical trials

By Lilian Zhang and Nikhil Bhojwani

Biopharma ,
Medtech ,
Digital ,

Digital biomarkers are no longer just a pipe dream—they are here, and their use is potentially at an inflection point. However, successful implementation requires more than enthusiasm; it demands thoughtful strategies tailored to each clinical innovation, therapeutic area, and digital tool.

Aug 2024

A Kaplan-Meier view of oncology development

By Lilian Zhang, Jason Brauner, and Marc Herant

Biopharma ,
Digital ,

We refresh a prior analysis of two cohorts of oncology development pro…

Dec 2023

Multi-Cancer Early Detection tests – Will they become part of regular clinical care?

By Sarah Dolman

PDF here Summary The idea of a single blood-test to detect many cancer…

Dec 2021

The road ahead for genomic testing

By Sarah Dolman

Biopharma ,
Payers ,
Medtech ,

New molecular diagnostics, especially tests based on next-generation s…

Jun 2020

AI in healthcare III: COVID-19 applications and implications

By Sophie Ranen and Nikhil Bhojwani

Biopharma ,
Payers ,
Providers ,
Medtech ,
Digital ,

COVID-19 has accelerated the adoption of AI in healthcare. AI based to…

Apr 2020

Strategy in the Time of Covid

By Nikhil Bhojwani

Biopharma ,
Payers ,
Providers ,
Medtech ,
Digital ,

Preamble A recent post from Recon Strategy outlined the longer-term st…

Apr 2020

The day after: Implications for hospitals, payers, biotech and more…

By Nikhil Bhojwani

Biopharma ,
Payers ,
Providers ,
Medtech ,
Digital

Even as our priority today is dealing with the Covid crisis, healthcar…

Nov 2018

New class of therapeutics calls for new regulations: thoughts on the FDA’s new process for regulating digiceuticals

By Tess Niewood

Medtech ,
Digital

Interest and investment in digital health has increased rapidly in rec…

Jun 2016

Attacking an oligopoly by integrating downstream services: Can Livongo’s closed loop get traction vs. the big glucometer incumbents?

By Tory Wolff

Medtech ,
Digital ,

Summary Livongo is marrying a cellular-enabled glucometer and a data …

May 2016

The future of cancer care: A bird’s-eye view

By Nikhil Bhojwani

Biopharma ,
Medtech

The recent World Medical Innovation Forum on Cancer convened by Partne…

May 2016

When is a patient not a patient? More often than you think

By Alex Brown

Medtech ,
Digital ,

I have been conducting an informal test for the past year and a half. …

May 2014

Boiling the Ocean…or not

By Nikhil Bhojwani

Payers ,
Providers ,
Digital ,